 |
|
Hormone might cause dangerous pregnancy complication
October 18, 2005CINCINNATI-Researchers at the University of Cincinnati (UC) Academic Health Center have found evidence of a hormone they say is responsible for certain types of high blood pressure (hypertension), and could also cause preeclampsia, a potentially dangerous condition that occurs during pregnancy.
Work is now under way to locate and identify the hormone, which is believed to be produced in very small, but highly potent amounts, so that its hypertension-causing action can be blocked.
Finding and neutralizing this "new player" in the mechanism of hypertension, the UC scientists said, could provide a breakthrough in the prevention of preeclampsia-which so far has been essentially untreatable-and other hypertensive conditions.
One of the Cincinnati research team's areas of interest, preeclampsia is a leading cause of fetal complications, which include low birth weight, premature birth and stillbirth. It can lead to seizures, known as eclampsia, the second leading cause of maternal death in the United States.
The researchers, Jerry Lingrel, PhD, chair of the University of Cincinnati's Department of Molecular Genetics, Biochemistry and Microbiology, and Iva Dostanic-Larson, PhD, a postdoctoral fellow in the department, report the findings of their three-year study in the Oct. 17, 2005, online edition of the Proceedings of the National Academy of Sciences (PNAS).
The work was funded by grants from the U.S. National Institutes of Health (NIH) and the Heart and Stroke Foundation of Ontario.
The focus of their research, said Dr. Lingrel, the principal investigator, is an area in the human cell known as the "sodium pump," an enzyme (Na,K-ATPase) that has long been known to be involved in the regulation of blood pressure, excitability of muscle and nerve tissue and the uptake of a wide range of essential nutrients.
The sodium pump contains the target or "binding site" of a group of drugs called cardiac glycosides, such as digitalis, which are commonly used to control congestive heart failure by increasing blood pressure.
Cardiac glycosides, used by physicians for centuries to treat congestive heart failure, have largely been obtained from "external" sources like plants, and even frog skin.
The survival of this site in the cell over thousands of years of evolution, however, has led scientists to believe that it must also be present for something other than externally derived, man-made medications. They have been looking for a naturally occurring, internal or "endogenous" control agent.
The University of Cincinnati scientists say in their PNAS report that they have found "conclusive evidence" that the cardiac glycoside binding site is also the receptor for an agent that occurs naturally in the body. This finding in turn supports a long-held hypothesis that there must be a hormone in the body that regulates blood pressure by interacting with the Na,K-ATPase binding site.
The next step, the Cincinnati researchers say, is to positively identify the hormone, which they believe should be a relatively routine although painstaking procedure, so that its level can be manipulated to control blood-pressure problems such as preeclampsia.
"For centuries physicians have controlled cardiac function using compounds like digitalis from the foxglove plant, which are closely related to compounds found in the skin of a poisonous frog and the bark of an African tree once used to make poison arrows," said Dr. Lingrel, "and they all worked on the sodium pump binding site. "It turns out that almost all species, from fruit flies to humans, have a site that responds to these medications. The question is, did nature somehow keep the site all through evolution just so that people who manufacture drugs, or isolate them from plants, can use it as a target?
"No one would ever believe that," Dr. Lingrel said. "They'd say if it's been so highly conserved, it has a real role in biology. And that's what we have shown.
"The site, with its ability to regulate blood pressure, is there to respond to something that occurs naturally in the human body. We're now very close to finding it."
Dr. Dostanic-Larson genetically engineered a mouse model specifically for this project. By identifying and replacing just two nucleotides among the 3.2 billion "building" blocks in mouse DNA, she was able to knock out the binding site's ability to function without altering the enzyme's other essential functions.
By altering the two nucleotides, the normally glycoside-sensitive target area in the sodium pump was made resistant to the glycoside drug ouabain.
The researchers found that long-term, low-dose administration of the human hormone ACTH (adrenocorticotropic hormone) caused hypertension in wild-type control mice, but not in the ouabain-resistant animals. This, the researchers say, demonstrates for the first time that some substance produced naturally by the body must be a major regulator of blood pressure.
"The point," Dr. Lingrel explained, "is that when the binding site is removed, the compound produced by the body can't interact with it, and therefore blood pressure is not regulated. In the logic of biochemistry, the compound interacting with the site has to be a steroid, and most probably a steroid hormone."
"The 'breakthrough,' if you like," said Dr. Lingrel, "is in saying that the binding site not only interacts with drugs, but there must be some substance the body makes that interacts with this site. That's the bottom line of this research.
"Once you know that blood pressure regulation occurs as a result of interaction between the binding site and a hormone-or one of several hormones-you can neutralize the hormone, probably with a monoclonal antibody (an antibody engineered in a laboratory to react with a specific target), and then the hypertension patient is going to be in good shape."
A degree of hypertension is necessary in normal pregnancy, said Dr. Dostanic-Larson, so that enough blood gets to the baby. In some women, however, the hormone regulation goes wrong, increasing blood pressure too much and causing preeclampsia.
"This new player, when we identify it," Dr. Dostanic-Larson said, "is highly likely to be overproduced in preeclampsia. The next step is to chase down the hormone. But in the meantime, we have a backup, because we know where the receptor is, and an alteration that changes the reaction between the hormone and the receptor will abolish this kind of hypertension."
Preeclampsia typically starts after the 20th week of pregnancy, mostly in first-time pregnancies, and is related to increased blood pressure and protein in the mother's urine, resulting from kidney problems. It affects the placenta, and can affect the mother's kidney, liver and brain.
In a commentary on the research, Jack Kaplan, PhD, chair of the Department of Biochemistry and Molecular Genetics at the University of Illinois at Chicago, said this "important work" provides a first clear demonstration that some substance within the body binds to Na,K-ATPase and is one of the regulators of blood pressure.
According to the National Heart, Lung and Blood Institute (NHLBI) of the NIH, there has been no proven way to prevent preeclampsia, and the only "cure" is to deliver the baby. More than 146,320 cases of preeclampsia were diagnosed in the United States in1998, the NHLBI says.
University of Cincinnati
One of the Cincinnati research team's areas of interest, preeclampsia is a leading cause of fetal complications, which include low birth weight, premature birth and stillbirth. It can lead to seizures, known as eclampsia, the second leading cause of maternal death in the United States.
The researchers, Jerry Lingrel, PhD, chair of the University of Cincinnati's Department of Molecular Genetics, Biochemistry and Microbiology, and Iva Dostanic-Larson, PhD, a postdoctoral fellow in the department, report the findings of their three-year study in the Oct. 17, 2005, online edition of the Proceedings of the National Academy of Sciences (PNAS).
The work was funded by grants from the U.S. National Institutes of Health (NIH) and the Heart and Stroke Foundation of Ontario.
The focus of their research, said Dr. Lingrel, the principal investigator, is an area in the human cell known as the "sodium pump," an enzyme (Na,K-ATPase) that has long been known to be involved in the regulation of blood pressure, excitability of muscle and nerve tissue and the uptake of a wide range of essential nutrients.
The sodium pump contains the target or "binding site" of a group of drugs called cardiac glycosides, such as digitalis, which are commonly used to control congestive heart failure by increasing blood pressure.
Cardiac glycosides, used by physicians for centuries to treat congestive heart failure, have largely been obtained from "external" sources like plants, and even frog skin.
The survival of this site in the cell over thousands of years of evolution, however, has led scientists to believe that it must also be present for something other than externally derived, man-made medications. They have been looking for a naturally occurring, internal or "endogenous" control agent.
The University of Cincinnati scientists say in their PNAS report that they have found "conclusive evidence" that the cardiac glycoside binding site is also the receptor for an agent that occurs naturally in the body. This finding in turn supports a long-held hypothesis that there must be a hormone in the body that regulates blood pressure by interacting with the Na,K-ATPase binding site.
The next step, the Cincinnati researchers say, is to positively identify the hormone, which they believe should be a relatively routine although painstaking procedure, so that its level can be manipulated to control blood-pressure problems such as preeclampsia.
"For centuries physicians have controlled cardiac function using compounds like digitalis from the foxglove plant, which are closely related to compounds found in the skin of a poisonous frog and the bark of an African tree once used to make poison arrows," said Dr. Lingrel, "and they all worked on the sodium pump binding site. "It turns out that almost all species, from fruit flies to humans, have a site that responds to these medications. The question is, did nature somehow keep the site all through evolution just so that people who manufacture drugs, or isolate them from plants, can use it as a target?
"No one would ever believe that," Dr. Lingrel said. "They'd say if it's been so highly conserved, it has a real role in biology. And that's what we have shown.
"The site, with its ability to regulate blood pressure, is there to respond to something that occurs naturally in the human body. We're now very close to finding it."
Dr. Dostanic-Larson genetically engineered a mouse model specifically for this project. By identifying and replacing just two nucleotides among the 3.2 billion "building" blocks in mouse DNA, she was able to knock out the binding site's ability to function without altering the enzyme's other essential functions.
By altering the two nucleotides, the normally glycoside-sensitive target area in the sodium pump was made resistant to the glycoside drug ouabain.
The researchers found that long-term, low-dose administration of the human hormone ACTH (adrenocorticotropic hormone) caused hypertension in wild-type control mice, but not in the ouabain-resistant animals. This, the researchers say, demonstrates for the first time that some substance produced naturally by the body must be a major regulator of blood pressure.
"The point," Dr. Lingrel explained, "is that when the binding site is removed, the compound produced by the body can't interact with it, and therefore blood pressure is not regulated. In the logic of biochemistry, the compound interacting with the site has to be a steroid, and most probably a steroid hormone."
"The 'breakthrough,' if you like," said Dr. Lingrel, "is in saying that the binding site not only interacts with drugs, but there must be some substance the body makes that interacts with this site. That's the bottom line of this research.
"Once you know that blood pressure regulation occurs as a result of interaction between the binding site and a hormone-or one of several hormones-you can neutralize the hormone, probably with a monoclonal antibody (an antibody engineered in a laboratory to react with a specific target), and then the hypertension patient is going to be in good shape."
A degree of hypertension is necessary in normal pregnancy, said Dr. Dostanic-Larson, so that enough blood gets to the baby. In some women, however, the hormone regulation goes wrong, increasing blood pressure too much and causing preeclampsia.
"This new player, when we identify it," Dr. Dostanic-Larson said, "is highly likely to be overproduced in preeclampsia. The next step is to chase down the hormone. But in the meantime, we have a backup, because we know where the receptor is, and an alteration that changes the reaction between the hormone and the receptor will abolish this kind of hypertension."
Preeclampsia typically starts after the 20th week of pregnancy, mostly in first-time pregnancies, and is related to increased blood pressure and protein in the mother's urine, resulting from kidney problems. It affects the placenta, and can affect the mother's kidney, liver and brain.
In a commentary on the research, Jack Kaplan, PhD, chair of the Department of Biochemistry and Molecular Genetics at the University of Illinois at Chicago, said this "important work" provides a first clear demonstration that some substance within the body binds to Na,K-ATPase and is one of the regulators of blood pressure.
According to the National Heart, Lung and Blood Institute (NHLBI) of the NIH, there has been no proven way to prevent preeclampsia, and the only "cure" is to deliver the baby. More than 146,320 cases of preeclampsia were diagnosed in the United States in1998, the NHLBI says.
University of Cincinnati
Pregnancy Complications Current Events and Pregnancy Complications News RSSWeight-loss surgery can break a family's cycle of obesity
Adolescent and young children of obese mothers who underwent weight-loss surgery prior to pregnancy have been found to have a lower prevalence of obesity and significantly improved cardio-metabolic markers when compared to siblings born before the same obese mothers had weight-loss surgery.
Pregnancy complications are a stress test for future maternal health and pregnancies
Predicting whether pregnancy complications affect long-term maternal health as well as future pregnancies is at the heart of two studies conducted by researchers in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine.
Women with endometriosis need special care during pregnancy to avoid risk of premature birth
The largest study to date of endometriosis in pregnant women has found that the condition is a major risk factor for premature birth.
Complications early in pregnancy or in previous pregnancies adversely affect existing or subsequent pregnancies
Complications in early pregnancy or in previous pregnancies can predict the likelihood of further problems in current or subsequent pregnancies, according to research carried out by an international group of experts.
Management of asthma during pregnancy can optimize health of mother and baby
Pregnant women with asthma, the most common condition affecting the lungs during pregnancy, should actively manage their asthma in order to optimize the health of mother and the baby, according to new management recommendations published in the current issue of the New England Journal of Medicine.
A reversal of thinking: How women with lupus can increase chance for healthy pregnancies
In the not so distant past, women with systemic lupus erythematosus (SLE), an autoimmune disease, were advised not to have children, and if they became pregnant, to have therapeutic abortions to prevent severe flares of their lupus.
Depression during pregnancy can double risk of preterm delivery
Depressed pregnant women have twice the risk of preterm delivery than pregnant women with no symptoms of depression, according to a new study by the Kaiser Permanente Division of Research.
Statins may prevent miscarriages
Hospital for Special Surgery researchers have found that statins may be able to prevent miscarriages in women who are suffering from pregnancy complications caused by antiphospholipid syndrome (APS), according to a study in mice.
Post-term pregnancies risk infant's life and health, UCSF studies show
Infants born more than one week past their due dates have a higher risk of both impaired health and death, according to two new studies by authors from the University of California's San Francisco and Berkeley campuses.
Newly-defined factors may prevent postpartum smoking relapse
Although many women quit smoking during pregnancy to protect their unborn children from the effects of cigarettes, half of them resume the habit within a few months of giving birth.
More Pregnancy Complications Current Events and Pregnancy Complications News Articles
 |
Williams Manual of Obstetrics: Pregnancy Complications, Twenty-Second Edition by Kenneth Leveno (Author), F. Cunningham (Author), James Alexander (Author), Steven Bloom (Author), Brian Casey (Author), Jodi Dashe (Author), Jeanne Sheffield (Author), Scott Roberts (Author) A portable, pocket-sized manual based on the world's leading obstetrics text-revised and updated! "This is a comprehensive review of pregnancy complications in an easy to access format. It provides quick but comprehensive information and is very easy to read. 3 Stars."--Doody's Review Service All the key facts, diagnostic tools, and treatment guidelines from the trusted Williams Manual of Obstetrics are right in the palm of your hand with this streamlined, carry-anywhere sourcebook. Inside, you'll find the rigorously referenced, evidence-based approach of the classic parent text, presented in a condensed format for easy access. The first section-packed with practical, at-a-glance information-takes you through the crucial steps for managing... |
 |
A Little Help from My Friends Also With: WB (Producer) |
 |
The Birth Partner, Third Edition: A Complete Guide to Childbirth for Dads, Doulas, and All Other Labor Companions (Birth Partner: A Complete Guide to Childbirth for Dads, Doulas, &) by Penny Simkin (Author) If you want to learn how best to help an expectant mother have a happy and healthy childbirth, The Birth Partner, Third Edition is the only book you'll need. For almost 20 years, husbands, partners, friends, relatives, and doulas have turned to this book for guidance on being a supportive partner in the delivery room. The expanded third edition includes the most up-to-date information about techniques, devices, and medications for easing labor pain; tests and treatments of the fetus and newborn; strategies to help labor progress; potential medical procedures and interventions; and how best to help the mother during the early days after the birth. And, with its easy-to-use format and new illustrations, the The Birth Partner is the essential guide have on hand in the delivery room. |
 |
Pregnancy After a Loss: A Guide to Pregnancy After a Miscarriage, Stillbirth, or Infant Death by Carol Cirulli Lanham (Author) "A 'must-have' guide for the devastated couple dealing with the many questions and fears that occur with a subsequent pregnancy." --Candace Hurley, Executive Director/Founder, Sidelines National Support Network For a woman who has experienced a miscarriage, stillbirth, or the death of an infant, conceiving another child can be fraught with mixed emotions. This guide, filled with up-to-date medical information and written by a woman who herself experienced a successful pregnancy after the loss of her first baby, can help women cope with their anxiety. It offers guidance for women asking such questions as: * Why did it happen--and how can I make sure it doesn't happen again? * Will my next pregnancy be considered high-risk? * How long should I wait before getting pregnant again? *... |
 |
Avoiding Miscarriage: Everything You Need To Know To Feel More Confident In Pregnancy by Susan Rousselot (Author) Written in the warm and accessible manner of a knowledgeable girlfriend, this highly unique book is the first to enable women to evaluate their own risk of miscarriage and take steps to reduce that risk. There are only four major causes of miscarriage, and targeted questionnaires help each woman clarify whether she might be at higher risk in any of these areas. Each cause is explained thoroughly but clearly, with the information and support women need to improve their chance of future successful pregnancy. This makes the book as relevant for women who have never even been pregnant as it is for women who have experienced miscarriage. The book presents a detailed overview of miscarriage, dispels common myths, provides flow charts to help reveal the cause of any... |
 |
Manual of High Risk Pregnancy and Delivery by Elizabeth S. Gilbert RNC MS FNPc (Author) With today's technologic advances and the help of knowledgeable nurses, women have a better chance of having a positive outcome of even a high risk pregnancy and delivery than ever before. Manual of High Risk Pregnancy & Delivery, 4th Edition provides the user with comprehensive information in a concise, accessible format. The book presents various problems in a consistent format that includes incidence, etiology, physiology, pathophysiology, and medical management with protocols for nurse practitioners. It also addresses collaborative problems and desired outcomes. Includes current AWHONN Standards of Practice.Current information on domestic violence and multiple gestation, including nutritional needs and preterm management.Features comprehensive coverage of substance abuse and... |
 |
Medical Management of Pregnancy Complicated by Diabetes, 4th Edition by Lois Jovanovic (Author) The most trusted reference on treating pregnancy with diabetes is back in a new edition Pregnancy complicated by diabetes is a medical challenge that can be minimized through a program of expert protocols and patient partnerships. This book presents a complete package of these protocols that when followed, can help produce healthy infants in pregnancies complicated by type 1, type 2, and gestational diabetes. Based on an ADA Technical Review, this fourth edition provides up-to-date information that includes: new guidelines for treatment using the new insulin analogues; a discussion on the use of oral hypoglycemic agents in pregnancy; and the latest in obstetrical surveillance of pregnant women with diabetes. |
 |
Chesley's Hypertensive Disorders in Pregnancy, Third Edition by Marshall D. Lindheimer MD FACP (Editor), James M. Roberts (Editor), F. Gary Cunningham (Editor) Hypertensive disorders remain one the major causes of maternal and fetal morbidity and death. It is also a leading cause of preterm birth now known to be a risk factor in remote cardiovascular disease. Despite this the hypertensive disorders remain marginally studied and management is often controversial. Chesley's Hypertensive Disorders in Pregnancy, remains one of the beacons to guide this field, recognized for its uniqueness and utility. The Third Edition continues this tradition, focusing on prediction, prevention, and management for clinicians, and is an essential reference text for clinical and basic investigators alike. Differing from other texts devoted to preeclampsia, it covers the whole gamut of high blood pressure, and not just preeclampsia. ... |
 |
Heart Disease in Pregnancy by Celia Oakley (Editor), Carole A. Warnes (Editor) The new edition of this practical guide draws on the clinical skills of a wide range of international experts to help you recognize and manage heart disease in pregnancy. Designed for on-the-spot use, this convenient and concise text helps you identify a cardiac problem, understand its pathophysiology, and respond appropriately. Under the careful editorial direction of Drs. Oakley and Warnes, the Second Edition introduces new contributors from North America and Europe as well as new chapters on: pulmonary hypertension rheumatic heart disease artificial heart valves Marfan syndrome auto-immune diseases hypertrophic cardiomyopathy rhythm disorders hypertension cardiac intervention The entire book is scrupulously... |
![A Little Help from My Friends [HD]](http://ecx.images-amazon.com/images/I/51KfjKb5JWL._SL160_.jpg) |
A Little Help from My Friends [HD] Also With: WB (Producer) |
| © 2009 BrightSurf.com |